top of page

News

Jan 30

Halia Therapeutics to Present at the 2023 BIO CEO & Investor Conference

Jan 19

Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as CMO

Jan 18

Halia Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Dec 1, 2022

Halia Therapeutics Presents at 4th Inflammasome Therapeutics Summit

Jun 15, 2022

Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184

Mar 30, 2022

Halia Therapeutics Presented Data on Targeting the NLRP3 Inflammasome in Alzheimer's Disease

bottom of page